Pear Bio

Patient-centered Cancer Precision Medicine

Natick, United States · Founded 2017

Employees
11–50
Founded
2017
Business Model
B2B
Last Round
Series AApr 2023
Rounds
2

About

Pear Bio is a functional precision medicine company that develops personalized cancer treatment tests and novel therapeutics. The platform takes tumor biopsies from patients, converts them into 3D immune-microtumors, and tests multiple treatment options side-by-side to predict response and match patients with effective therapies. Excess tissue is characterized to identify new drug targets for cancers with high unmet need. Founded in 2017, Pear Bio serves both oncology drug discovery teams and individual cancer patients through its personalized testing services and computational biology platform.

Summary

Pear Bio is a Biotech company based in Natick, United States, founded in 2017. Its most recent funding was a Series A round in Apr 2023. Investors include SOSV, octopus investments and Hoxton Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AApr 2023

Sign up to see all 2 events

Funding: Grant through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Pear Bio on Indexed.vc
<a href="https://indexed.vc/companies/pear-bio"><img src="https://indexed.vc/api/badge/company/pear-bio" alt="Pear Bio on Indexed.vc" width="260" height="76" /></a>